PRMT6 overexpression upregulates TSP-1 and downregulates MMPs: Its implication in motility and invasion

Biochemical and Biophysical Research Communications

Volumn 432, Issue 1, 2013, Pages 60-65

  Kim, Nam Hyun ^a   Kim, Su Nam ^b   Seo, Dong Wan ^c   Han, Jeung Whan ^d   Kim, Yong Kee ^e  

^a Kwandong University College of Medicine   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

^c Dankook University   (South Korea)

^d Sungkyunkwan University   (South Korea)

^e Sookmyung Women's University   (South Korea)

Author keywords

Invasion; Migration; PRMT6; Thrombospondin 1

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; GELATINASE A; GELATINASE B; GREEN FLUORESCENT PROTEIN; MATRIX METALLOPROTEINASE; PROTEIN ARGININE METHYLTRANSFERASE; PROTEIN ARGININE METHYLTRANSFERASE 6; THROMBOSPONDIN 1; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL STRAIN MCF 7; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; GENE SILENCING; GROWTH RATE; HUMAN; HUMAN CELL; MALE; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MCF-7 CELLS; NEOPLASM INVASIVENESS; NUCLEAR PROTEINS; PROSTATIC NEOPLASMS; PROTEIN-ARGININE N-METHYLTRANSFERASES; THROMBOSPONDIN 1;

EID: 84875370818     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.01.085     Document Type: Article

References (35)

1. Hassa P.O., Covic M., Bedford M.T., Hottiger M.O. Protein arginine methyltransferase 1 coactivates NF-kappaB-dependent gene expression synergistically with CARM1 and PARP1. J. Mol. Biol. 2008, 377:668-678.
2. McBride A.E., Silver P.A. State of the arg: protein methylation at arginine comes of age. Cell 2001, 106:5-8.
3. Tang J., Gary J.D., Clarke S., Herschman H.R. PRMT 3, a type I protein arginine N-methyltransferase that differs from PRMT1 in its oligomerization, subcellular localization, substrate specificity, and regulation. J. Biol. Chem. 1998, 273:16935-16945.
4. Torres-Padilla M.E., Parfitt D.E., Kouzarides T., Zernicka-Goetz M. Histone arginine methylation regulates pluripotency in the early mouse embryo. Nature 2007, 445:214-218.
5. Bedford M.T., Clarke S.G. Protein arginine methylation in mammals: who, what, and why. Mol. Cell 2009, 33:1-13.
6. Zurita-Lopez C.I., Sandberg T., Kelly R., Clarke S.G. Human protein arginine methyltransferase 7 (PRMT7) is a type III enzyme forming omega-NG-monomethylated arginine residues. J. Biol. Chem. 2012, 287:7859-7870.
7. Bedford M.T. Arginine methylation at a glance. J. Cell Sci. 2007, 120:4243-4246.
8. Krause C.D., Yang Z.H., Kim Y.S., Lee J.H., Cook J.R., Pestka S. Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential. Pharmacol. Ther. 2007, 113:50-87.
9. Vallance P., Leiper J. Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway. Arterioscler., Thromb., Vasc. Biol. 2004, 24:1023-1030.
10. Pal S., Vishwanath S.N., Erdjument-Bromage H., Tempst P., Sif S. Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes. Mol. Cell. Biol. 2004, 24:9630-9645.
11. El-Andaloussi N., Valovka T., Toueille M., Steinacher R., Focke F., Gehrig P., Covic M., Hassa P.O., Schar P., Hubscher U., Hottiger M.O. Arginine methylation regulates DNA polymerase beta. Mol. Cell 2006, 22:51-62.
12. Hyllus D., Stein C., Schnabel K., Schiltz E., Imhof A., Dou Y., Hsieh J., Bauer U.M. PRMT6-mediated methylation of R2 in histone H3 antagonizes H3 K4 trimethylation. Genes Dev. 2007, 21:3369-3380.
13. Frankel A., Yadav N., Lee J., Branscombe T.L., Clarke S., Bedford M.T. The novel human protein arginine N-methyltransferase PRMT6 is a nuclear enzyme displaying unique substrate specificity. J. Biol. Chem. 2002, 277:3537-3543.
14. Miranda T.B., Webb K.J., Edberg D.D., Reeves R., Clarke S. Protein arginine methyltransferase 6 specifically methylates the nonhistone chromatin protein HMGA1a. Biochem. Biophys. Res. Commun. 2005, 336:831-835.
15. Zou Y., Webb K., Perna A.D., Zhang Q., Clarke S., Wang Y. A mass spectrometric study on the in vitro methylation of HMGA1a and HMGA1b proteins by PRMTs: methylation specificity, the effect of binding to AT-rich duplex DNA, and the effect of C-terminal phosphorylation. Biochemistry 2007, 46:7896-7906.
16. Waldmann T., Izzo A., Kamieniarz K., Richter F., Vogler C., Sarg B., Lindner H., Young N.L., Mittler G., Garcia B.A., Schneider R. Methylation of H2AR29 is a novel repressive PRMT6 target. Epigenetics Chromatin 2011, 4:11.
17. Yoshimatsu M., Toyokawa G., Hayami S., Unoki M., Tsunoda T., Field H.I., Kelly J.D., Neal D.E., Maehara Y., Ponder B.A., Nakamura Y., Hamamoto R. Dysregulation of PRMT1 and PRMT6 Type I arginine methyltransferases, is involved in various types of human cancers. Int. J. Cancer 2011, 128:562-573.
18. Michaud-Levesque J., Richard S. Thrombospondin-1 is a transcriptional repression target of PRMT6. J. Biol. Chem. 2009, 284:21338-21346.
19. Kim N.H., Kim S.N., Kim Y.K. Involvement of HDAC1 in E-cadherin expression in prostate cancer cells; its implication for cell motility and invasion. Biochem. Biophys. Res. Commun. 2011, 404:915-921.
20. Johnsen M., Lund L.R., Romer J., Almholt K., Dano K. Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr. Opin. Cell Biol. 1998, 10:667-671.
21. Stetler-Stevenson W.G. Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev. 1990, 9:289-303.
22. Deryugina E.I., Quigley J.P. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 2006, 25:9-34.
23. Steeg P.S. Metastasis suppressors alter the signal transduction of cancer cells. Nat. Rev. Cancer 2003, 3:55-63.
24. Dawson D.W., Pearce S.F., Zhong R., Silverstein R.L., Frazier W.A., Bouck N.P. CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells. J. Cell Biol. 1997, 138:707-717.
25. Dawson D.W., Volpert O.V., Pearce S.F., Schneider A.J., Silverstein R.L., Henkin J., Bouck N.P. Three distinct D-amino acid substitutions confer potent antiangiogenic activity on an inactive peptide derived from a thrombospondin-1 type 1 repeat. Mol. Pharmacol. 1999, 55:332-338.
26. Jaffe E.A., Ruggiero J.T., Leung L.K., Doyle M.J., McKeown-Longo P.J., Mosher D.F. Cultured human fibroblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix. Proc. Natl. Acad. Sci. USA 1983, 80:998-1002.
27. Varani J., Riser B.L., Hughes L.A., Carey T.E., Fligiel S.E., Dixit V.M. Characterization of thrombospondin synthesis, secretion and cell surface expression by human tumor cells. Clin. Exp. Metastasis 1989, 7:265-276.
28. Asch A.S., Silbiger S., Heimer E., Nachman R.L. Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding. Biochem. Biophys. Res. Commun. 1992, 182:1208-1217.
29. Tuszynski G.P., Rothman V.L., Papale M., Hamilton B.K., Eyal J. Identification and characterization of a tumor cell receptor for CSVTCG, a thrombospondin adhesive domain. J. Cell Biol. 1993, 120:513-521.
30. Volpert O.V., Pili R., Sikder H.A., Nelius T., Zaichuk T., Morris C., Shiflett C.B., Devlin M.K., Conant K., Alani R.M. Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1. Cancer Cell 2002, 2:473-483.
31. Lih C.J., Wei W., Cohen S.N. Txr1: a transcriptional regulator of thrombospondin-1 that modulates cellular sensitivity to taxanes. Genes Dev. 2006, 20:2082-2095.
32. Phalke S., Mzoughi S., Bezzi M., Jennifer N., Mok W.C., Low D.H., Thike A.A., Kuznetsov V.A., Tan P.H., Voorhoeve P.M., Guccione E. P53-Independent regulation of p21Waf1/Cip1 expression and senescence by PRMT6. Nucleic Acids Res. 2012, 40:9534-9542.
33. Kleinschmidt M.A., de Graaf P., van Teeffelen H.A., Timmers H.T. Cell cycle regulation by the PRMT6 arginine methyltransferase through repression of cyclin-dependent kinase inhibitors. PLoS One 2012, 7:e41446.
34. Stein C., Riedl S., Ruthnick D., Notzold R.R., Bauer U.M. The arginine methyltransferase PRMT6 regulates cell proliferation and senescence through transcriptional repression of tumor suppressor genes. Nucleic Acids Res. 2012, 40:9522-9533.
35. Neault M., Mallette F.A., Vogel G., Michaud-Levesque J., Richard S. Ablation of PRMT6 reveals a role as a negative transcriptional regulator of the p53 tumor suppressor. Nucleic Acids Res. 2012, 40:9513-9521.